Research programme: C-type-lectin vaccine adjuvants- Inimmune
Latest Information Update: 04 Sep 2023
At a glance
- Originator Inimmune
- Class Viral vaccines
- Mechanism of Action C-type lectin agonists; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 08 Aug 2023 Preclinical trials in Unspecified in USA (unspecified route) (Inimmune pipeline)